AbbreviAtioNs CMR = complete microsurgical resection; ISCT = intramedullary spinal cord tumor; RMR = radical microsurgical resection; STR = subtotal resection; VHL = von Hippel-Lindau. objeCtive The objective of this study was to identify clinically relevant predictors of progression-free survival and functional outcomes in patients who underwent surgery for intramedullary spinal cord tumors (ISCTs). MethoDs An institutional spinal tumor registry and billing records were reviewed to identify adult patients who underwent resection of ISCTs between 1993 and 2014. Extensive data were collected from patient charts and operative notes, including demographic information, extent of resection, tumor pathology, and functional and oncological outcomes. Survival analysis was used to determine important predictors of progression-free survival. Logistic regression analysis was used to evaluate the association between an "optimal" functional outcome on the Frankel or McCormick scale at 1-year follow-up and various clinical and surgical characteristics. resUlts The consecutive case series consisted of 63 patients (50.79% female) who underwent resection of ISCTs. The mean age of patients was 41.92 ± 14.36 years (range 17.60-75.40 years). Complete microsurgical resection, defined as no evidence of tumor on initial postoperative imaging, was achieved in 34 cases (54.84%) of the 62 patients for whom this information was available. On univariate analysis, the most significant predictor of progression-free survival was tumor histology (p = 0.0027). Patients with Grade I/II astrocytomas were more likely to have tumor progression than patients with WHO Grade II ependymomas (HR 8.03, 95% CI 2.07-31.11, p = 0.0026) and myxopapillary ependymomas (HR 8.01, 95% CI 1.44-44.34, p = 0.017). Furthermore, patients who underwent radical or subtotal resection were more likely to have tumor progression than those who underwent complete resection (HR 3.46, p = 0.018). Multivariate analysis revealed that tumor pathology was the only significant predictor of tumor progression. On univariate analysis, the most significant predictors of an "optimal" outcome on the Frankel scale were age (OR 0.94, p = 0.0062), preoperative Frankel grade (OR 4.84, 
I
ntramedullary spinal cord tumors (ISCTs) comprise 2.0%-8.5% of all primary central nervous system lesions in both adult and pediatric patients. 1, 5 In adults, ependymomas are the most common ISCTs, followed by astrocytomas and hemangioblastomas. 18 Early surgical intervention is favorable in patients presenting with mild neurological deficits, as it improves functional status and results in long-term survival benefits. 7 Increasingly, aggressive tumor resections have been achievable due to microsurgical advances. 5 However, achieving complete resection must be balanced with the risk of peri-and postoperative neurological deficits. 7 Previous studies have indicated that preoperative neurological status and tumor histology are important predictors of functional outcomes, as are intraoperative monitoring, extent of resection, and adjuvant radiation therapy. 5, 6, 11, 22 The effect of other characteristics such as demographics, intraoperative factors, and postoperative findings are not well delineated. Moreover, there is a dearth of studies investigating long-term functional outcomes in patients with ISCTs. The present study provides a systematic analysis of ISCTs managed surgically by two spine surgeons at our institution and evaluates important predictors of tumor recurrence and postoperative functional outcomes.
Methods study Population
The study was approved by the Research Ethics Board of the University Health Network. Complete information was available on 63 patients who underwent resection for primary ISCTs at the Toronto Western Hospital, University Health Network, between January 1993 and December 2014. Myxopapillary ependymomas were included in the series if there was a confirmed intramedullary component of the tumor/conus involvement. While data from patients who underwent surgery prior to 2004 were collected retrospectively, data from patients who were treated after 2004 were entered consecutively into a surgical spinal registry.
surgical Procedure
Up-front surgery was recommended to all symptomatic patients. For patients who initially presented without symptoms, surgery was undertaken only following symptomatic or radiological progression. Surgeries were performed by two surgeons, with 55 of the 63 (87.30%) procedures performed by the senior author (M.G.F.).
Data Collection
Data collected included demographic information and preoperative neurological status as classified by the Frankel 8 and modified McCormick 4 scales (Tables 1 and 2 ). Each patient underwent neurological examination in the postoperative period. Length of hospital stay was also recorded. Reports from staff neuropathologists and neuroradiologists were used to confirm the histopathology of the tumor and describe the postoperative MRI imaging changes, respectively. Complete microsurgical resection (CMR) refers to the absence of residual tumor on initial postoperative MRI studies, while radical microsurgical resection (RMR) describes a tumor residual of < 20% on MRI. In cases in which there was uncertainty as to whether the postoperative MRI finding represented residual tumor, intraoperative findings were taken into account. Subtotal resection (STR) was defined as an incomplete resection of the bulk tumor. Functional and neurological status at 1-and 2-year follow-ups were classified by Frankel grades and McCormick scores.
statistical Analysis
Continuous predictors were summarized using means, medians, standard deviations, and ranges. Categorical variables were described using frequencies and percentages. Survival analysis was performed to determine key predictors of tumor progression following surgery, as evidenced by postoperative MRI. Kaplan-Meier curves were plotted for categorical variables, and log-rank tests were conducted to assess overall significance. Cox proportional hazards regression analysis was performed to compute hazard ratios, 95% confidence intervals, and levels of significance. We explored the predictive value of general demographics (age, sex, and preoperative neurological status), tumor characteristics (spinal region, extent of tumor, and histology), and surgical factors (extent of resection, number of levels). Multivariate analysis was conducted on variables that yielded a p value of < 0.2 on univariate analysis.
A secondary analysis was performed to evaluate key predictors of postoperative functional outcomes. Changes in Frankel and McCormick scores were determined by subtracting 1-year scores from preoperative scores. Lo- gistic regression analysis was used to evaluate the association between an "optimal" outcome and several demographic, tumor-related, and surgical factors. Patients were classified as having an "optimal" outcome if 1) they had a preoperative Frankel grade of C or D or a McCormick score of II, III, or IV and improved by 1 or more point or 2) they had an initial Frankel score of E or a McCormick score of I and remained stable following surgery. A "suboptimal" outcome was defined as a decline in Frankel (e.g., from D to C) or McCormick score (e.g., from II to III), or no improvement if the preoperative Frankel and McCormick scores were C or D and II, III, or IV, respectively.
results baseline and surgical Characteristics
Our series consisted of 32 (50.79%) females and 31 (49.21%) males, whose mean age was 41.92 ± 14.36 years (range 17.60-75.40 years). On initial presentation, the majority of patients presented with symptoms consistent with Frankel Grade D (73.02%) ( Table 1 ) and mild to moderate motor or sensory deficit, as classified using the modified McCormick Scale (Grades II-III; 71.43%) ( Table 2) .
Classic ependymomas (WHO Grade II) were the most frequent tumor subtype (46.03%) followed by myxopapillary ependymomas (17.46%), WHO Grade I/II astrocytomas (12.70%) and hemangioblastomas (11.11%). Of the patients with hemangioblastomas, 42.9% (3 of 7) had known von Hippel-Lindau (VHL) syndrome. Representative imaging is shown in Fig. 1 . Other pathological types included subependymomas (3.17%), cavernous malformations (3.17%), Grade III/IV astrocytomas (3.17%), an oligodendroglioma (1.59%), and a primitive neuroectodermal tumor (1.59%); patients with these lesions were excluded from pathology risk factor analysis due to insufficient sample sizes for each histopathological classification.
Tumors spanned an average of 4.65 ± 1.67 spinal levels (range 2-11). Twenty-nine patients (46.03%) had a lesion located in the cervical region, 3 (4.76%) in the cervicothoracic segments, 15 (23.81%) in the thoracic segments, and 16 (25.40%) in the conus. The extent of resection was not available for 1 patient. A CMR was achieved in 34 of 62 cases (54.84%), an RMR in 18 (29.03%), and an STR in 10 (16.13%). CMR was achieved in the majority of patients with WHO Grade II ependymomas (75.86%), myxopapillary ependymomas (63.64%), and hemangioblastomas (57.14%) (Fig. 2) . The median length of hospital stay following surgery was 8 days (n = 55). 
Predictors of Progression-Free survival

Univariate Analysis
The results from univariate analysis are summarized in Table 3 . In this series, 19 patients (30.16%) experienced clinical and/or radiological progression of disease. There was no significant difference in age or sex between patients who did (38.35 ± 12.99 years, 57.89% male) and did not (43.50 ± 14.79, 45.45%) experience tumor progression (p = 0.24 and p = 0.71 for age and sex, respectively). On univariate analysis, the most significant predictor of progression-free survival was tumor histology (p = 0.0027) ( 
Multivariate Analysis
Following multivariate analysis, the only significant predictor of tumor progression was tumor pathology. Although the extent of residual disease was no longer significant, tumor pathology likely encompasses this variable. In particular, surgical management of infiltrative lesions such as astrocytomas involves subtotal resection. Most importantly, patients with Grade I/II astrocytomas were at a significantly higher risk of progression than those with classic ependymomas.
Predictors of Functional outcomes at 1-year Follow-Up
Functional outcomes were determined based on change in Frankel On univariate analysis, the most significant predictors of an "optimal" outcome on the Frankel scale were age (OR 0.94, 95% CI 0.89-0.98, p = 0.0062) and preoperative Frankel (OR 4.84, 95% CI 1.33-17.63, p = 0.017) and McCormick (OR 0.22, 95% CI 0.084-0.57, p = 0.0018) scores. Patients who achieved an "optimal" outcome had a greater number of decompressed levels (5.30 ± 2.28) than those who did not (4.18 ± 1.10), although this relationship did not reach statistical significance (OR 0.67, 95% CI 0.44-1.005, p = 0.053). Patients with a tumor in the cervical (OR 0.067, 95% CI 0.012-0.38, p = 0.0023) and thoracic (OR 0.015, 95% CI 0.001-0.20, p = 0.0013) regions were less likely to achieve an "optimal" outcome than patients with a tumor in the conus medullaris (Table 4) . Furthermore, patients who underwent a CMR were more likely to achieve an "optimal" outcome than patients who had a subtotal or radical resection (OR 0.35, 95% CI 0.11-1.14, p = 0.081); however, this association did not reach statistical significance. Sex (p = 0.44) was not an important predictor of postoperative Frankel outcomes. Compared with myxopapillary ependymoma, patients with WHO Grade II ependymomas (OR 0.044, 95% CI 0.005-0.41, p = 0.0060) and Grade I/II astrocytomas (OR 0.037, 95% CI 0.003-0.50, p = 0.013) were less likely to achieve an "optimal" outcome on the Frankel scale.
Using the McCormick classification, age was a significant predictor of an "optimal" outcome (OR 0.94, 95% CI 0.90-0.98, p = 0.0045). Tumor pathology was also significantly associated with outcomes: patients with myxopapillary ependymomas (WHO Grade I) were more likely to achieve an "optimal" outcome than patients with WHO 
Discussion
Resection of ISCTs is the favored first-line approach for patients presenting with neurological impairment. Additionally, as surgical techniques continue to advance, it is expected that patient outcomes will improve and that risks associated with resection will decrease. 10 The present study describes a large case series in Canada and is the first review of ISCTs at our institution.
The findings from this study provide strong support that tumor histology is the most important predictor of tumor progression. On univariate analysis, residual tumor was associated with a lower rate of progression-free survival; however, all patients who underwent RMR or STR had astrocytic tumors or tumors of malignant histology. By contrast, CMR and RMR were achieved in the majority of patients with WHO Grade II ependymomas, myxopapillary ependymomas, and hemangioblastomas. This finding suggests that the relationship between extent of tumor resection and progression is likely reflective of the underlying tumor pathology. This is consistent with a published single-center case series of 102 patients surgically treated for ISCTs, 12 which reported that histopathology predicts extent of resection as well as tumor recurrence. Most ependymomas have a more defined surgical plane in contrast to astrocytomas, which have no surgical plane. The presence of a tumor resection plane alone has been shown to improve progressionfree survival, irrespective of tumor histology. 9, 13, 21 However, although postoperative residual tumor is an important predictor of progression, the aggressiveness of resection should be cautiously weighed against the risk of new postoperative neurological deficit.
3 Collectively, favorable histology combined with complete or radical resection favors long-term survival in patients with ISCTs.
Regarding functional outcomes, our results demonstrate that preoperative functional status, tumor histology and age are the most important predictors of stable or im- 2 The majority of patients with astrocytic tumors presented with no change or a decline in neurological status at 1-year follow-up. Previous studies of malignant ISCTs have demonstrated that aggressive resection may preserve neurological function, particularly in astrocytomas; however, this may be associated with a significant risk of decline in postoperative motor function. 16 Additionally, 3 patients with hemangioblastomas in our study were previously diagnosed with a genetic predisposition syndrome such as VHL syndrome. The authors of a large case series involving neurosurgical resection of hemangioblastomas in patients with VHL syndrome reported that 78% of their patients remained functionally stable during a 15-year follow-up. 17 Long-term decline was usually associated with disease progression secondary to other associated lesions. Numerous studies in the literature have demonstrated significant benefits, in terms of survival and quality of life, when hemangioblastomas were resected in VHL patients. 12, 14, 19, 20 Consistent with our findings of the importance of preoperative functional status in predicting postoperative functional outcomes, a clinical systematic review of the treatment of ISCTs concluded that a patient's preoperative neurological status is the most important factor in determining long-term postoperative neurological and functional outcomes. 11 In particular, improved postoperative ambulatory ability is more likely in patients with good preoperative neurological status, classified as either normal ambulation or mild motor sensory deficit with independent ambulation not requiring external aid. 15 Short-and long-term postoperative functional outcomes in patients with ISCTs are likely multifactorial and additional systematic analyses are needed to further delineate the most clinically relevant and measureable predictors.
limitations
Retrospective studies are subject to significant selection and information biases. In addition, large sample sizes are required to retrospectively study rare outcomes, such as tumor progression. Since our sample consisted of 63 patients, the confidence intervals for our estimates were wide, reflecting variability and relative imprecision. This study also did not assess the contribution of intraoperative variables to immediate and short-term neurological status. Additional studies investigating the impact of neuromonitoring and other operative parameters on outcomes for ISCTs are therefore warranted. Finally, since the modified McCormick and Frankel grading systems used in our study are relatively crude measures of outcome, future prospective studies should evaluate outcomes using more accurate measures of impairment such as the Standard for Neurological Classification of Spinal Cord Injury (SNCSCI).
Conclusions
This study demonstrates that tumor pathology is the most important predictor of progression-free survival in patients treated surgically for ISCTs. Long-term functional outcomes are expected to be most favorable in patients with myxopapillary ependymomas, younger age, and good preoperative functional status. We anticipate the results from this study will complement other similar case series in the literature and aid in the prediction of survival and outcomes in patients with ISCTs.
